| Financial Year |
March 31 2022 |
| Monetary Funds |
735,602,088.45 |
| Held-for-trading Financial Assets |
93,337,049.35 |
| Notes Receivable |
-- |
| Accounts Receivable |
36,239,499.24 |
| Advances to Suppliers |
108,584,267.81 |
| Other Receivables |
5,531,345.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
912,883,993.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,383,817.24 |
| Total Current Assets |
1,944,399,520.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
652,109,134.54 |
| Under-construction Projects |
111,584,753.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,378,793.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,601,442.12 |
| Deferred Income Tax Assets |
5,759,486.12 |
| Other Non-Current Assets |
6,246,168.24 |
| Sub-Total of Non-Current Assets |
915,679,778.40 |
| Total Assets |
2,860,079,298.81 |
| Short-Term Loans |
150,127,488.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
98,024,135.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,355,269.78 |
| Taxes Payable |
10,765,318.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,425,751.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
24,374,784.01 |
| Sub-Total of Current Liabilities |
728,509,057.13 |
| Long-term Loans |
100,094,444.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,663,665.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
135,549,884.53 |
| Total Liabilities |
864,058,941.66 |
| Paid-In Capital(Or Share Stock) |
309,441,175.00 |
| Capital Surplus |
451,922,737.32 |
| Surplus Reserve |
80,783,673.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,149,962,576.31 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,996,020,357.15 |
| Owner's Equity（Stockholder's Equity） |
1,996,020,357.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,860,079,298.81 |
